Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Grigg

Showing results (11-20 of 132) with videos related to

Pageof 14
Sort By:
Leukemia & Lymphoma|November 11, 2022
Optimizing the oral dose of cyclosporine with concomitant posaconazole post stem cell allograftJulia McClelland, Eric Wong, Andrew Grigg
European Journal of Haematology|February 3, 2012
Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropeniaPrahlad Ho, Peter Sherman, Andrew Grigg
British Journal of Haematology|March 30, 2010
The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adultsAnna Kalff, Claire Dowsing, Andrew Grigg
Leukemia & Lymphoma|July 25, 2013
Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyureaEmma Verner, Cecily Forsyth, Andrew Grigg
Clinical & Translational Immunology|August 2, 2021
Dilemmas in the diagnosis and pathogenesis of atypical late-onset familial haemophagocytic lymphohistiocytosisAdrian Minson, Ilia Voskoboinik, Andrew Grigg
The Lancet. Oncology|May 7, 2015
Programmed cell death-1 inhibition in lymphomaEliza A Hawkes, Andrew Grigg, Geoff Chong
Leukemia & Lymphoma|April 21, 2023
Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograftChih-Chiang Hu, Rakhee Subramanian, Andrew Grigg
Clinical Hematology International|February 7, 2023
Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell LymphomaEdward R Scheffer Cliff, Gemma Reynolds, Andrew Grigg
Journal of Gastroenterology and Hepatology|July 30, 2022
A critical evaluation of the role of iron overload in fatty liver diseaseMonique Fernandez, Julie Lokan, Christopher Leung, et al.
Current Opinion in Infectious Diseases|October 23, 2012
Making sense of posaconazole therapeutic drug monitoring: a practical approachMichelle R Ananda-Rajah, Andrew Grigg, Monica A Slavin
Pageof 14

Showing results (11-20 of 132) with videos related to

Sort By:
Pageof 14
Leukemia & Lymphoma|November 11, 2022
Optimizing the oral dose of cyclosporine with concomitant posaconazole post stem cell allograftJulia McClelland, Eric Wong, Andrew Grigg
European Journal of Haematology|February 3, 2012
Intermittent granulocyte colony-stimulating factor maintains dose intensity after ABVD therapy complicated by neutropeniaPrahlad Ho, Peter Sherman, Andrew Grigg
British Journal of Haematology|March 30, 2010
The impact of a regular erythrocytapheresis programme on the acute and chronic complications of sickle cell disease in adultsAnna Kalff, Claire Dowsing, Andrew Grigg
Leukemia & Lymphoma|July 25, 2013
Cyclical thrombocytosis, acquired von Willebrand syndrome and aggressive non-melanoma skin cancers are common in patients with Philadelphia-negative myeloproliferative neoplasms treated with hydroxyureaEmma Verner, Cecily Forsyth, Andrew Grigg
Clinical & Translational Immunology|August 2, 2021
Dilemmas in the diagnosis and pathogenesis of atypical late-onset familial haemophagocytic lymphohistiocytosisAdrian Minson, Ilia Voskoboinik, Andrew Grigg
The Lancet. Oncology|May 7, 2015
Programmed cell death-1 inhibition in lymphomaEliza A Hawkes, Andrew Grigg, Geoff Chong
Leukemia & Lymphoma|April 21, 2023
Evaluation of a safe neutrophil count for cessation of intravenous antibiotics and early hospital discharge in stable, afebrile patients recovering after acute myeloid leukemia therapy or an autograftChih-Chiang Hu, Rakhee Subramanian, Andrew Grigg
Clinical Hematology International|February 7, 2023
Disseminated Invasive Mucormycosis Infection Following Autologous Stem Cell Transplantation for Diffuse Large B-Cell LymphomaEdward R Scheffer Cliff, Gemma Reynolds, Andrew Grigg
Journal of Gastroenterology and Hepatology|July 30, 2022
A critical evaluation of the role of iron overload in fatty liver diseaseMonique Fernandez, Julie Lokan, Christopher Leung, et al.
Current Opinion in Infectious Diseases|October 23, 2012
Making sense of posaconazole therapeutic drug monitoring: a practical approachMichelle R Ananda-Rajah, Andrew Grigg, Monica A Slavin
Pageof 14